Italy’s biotech lobby sets a 2036 roadmap to boost national scientific and industrial capacityExecutive summary: Assobiotec launched its Horizon 2036 manifesto outlining requirements for Italy to fully leverage its scientific, industrial and social potential by 2036. The manifesto establishes a policy agenda that could shape biotech investment, R&D funding and regulatory frameworks in Italy. Assobiotec (Federchimica) and Italian government stakeholders, with implications for investors and research institutions. Discussion among policymakers and industry on implementation measures, including possible funding programs and regulatory adjustments.Assobiotec, the Italian association of chemical and biotech firms, published a strategic manifesto titled Horizon 2036 that defines the conditions for Italy to fully exploit its scientific, industrial and social potential by 2036. The document calls for clearer regulatory frameworks, targeted R&D funding and strengthened public‑private collaboration. It signals a long‑term policy agenda that could reshape the biotech landscape in Italy and influence related investment decisions.Connected developmentsGerman health‑saving package meets strong scepticismCroatia positions itself as Adriatic energy hubOpen the full case file on Beyond →
Social Pulse
AI estimate · not scraped